Sequenom Preliminary Full-year 2012 Revenues Grow 59 Percent to $89M | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom on Sunday said that it expects its full-year 2012 revenues to grow 59 percent year-over-year to $89 million.

Based on the company's preliminary financial results, diagnostic services grew more than five-fold during the year to about $46 million, compared to $8.3 million in 2011, while Genetic Analysis posted $43 million in sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.